Inventor · disambiguated record
Dylan Conklin
Also filed as: CONKLIN DYLAN
5 granted patents·12 pending applications·3 citations·filing 2014–2025
66Inventor score
Top patents by PatentIndex Score
17 records- 0191US12065489B2Claudin-6 antibodies and drug conjugatesUNIV CALIFORNIA·Filed 2022·Granted Aug 20, 2024·2 cites·59 claims
- 0287US11834499B1Claudin18 antibodies and methods of treating cancerUNIV CALIFORNIA·Filed 2022·Granted Dec 5, 2023·1 cites·99 claims
- 0381US2025333501A1Claudin 4 and claudin 9 antibodies and methods of treating cancerUNIV CALIFORNIA·Filed 2025·Application pending·0 cites
- 0480US2025066469A1Claudin-6 antibodies and drug conjugatesUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 0579US2024400674A1Claudin 4 and claudin 9 antibodies and methods of treating cancerUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 0672US2022372134A1Claudin6 antibodies and methods of treating cancerUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 0765US12345709B2CLAUDIN18 antibodies and methods of treating cancerUNIV CALIFORNIA·Filed 2020·Granted Jul 1, 2025·0 cites·15 claims
- 0863US2020291111A1Claudin6 antibodies and methods of treating cancerUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 0963US2022162299A1Claudin-6 antibodies and drug conjugatesUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 1062US2016138114A1Biomarkers of Response to Inhibition of Poly-ADP Ribose Polymerase (PARP) in CancerUNIV CALIFORNIA·Filed 2014·Application pending·0 cites
- 1159US2019048424A1Biomarkers of Response to Inhibition of Poly-ADP Ribose Polymerase (PARP) in CancerUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 1256US2017369950A1Biomarkers of Response to Inhibition of Poly-ADP Ribose Polymerase (PARP) in CancerUNIV CALIFORNIA·Filed 2017·Application pending·0 cites
- 1350US2019292605A1Biomarkers of Response to Cyclin D-CDK4/6 Targeted Therapies in CancerUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 1449US12486280B2CDK inhibitors and uses thereofCALIFORNIA INST OF TECHN·Filed 2019·Granted Dec 2, 2025·0 cites·23 claims
- 1547US12428416B2ERK inhibitors and uses thereofCALIFORNIA INST OF TECHN·Filed 2019·Granted Sep 30, 2025·0 cites·20 claims
- 1647US2022177583A1Claudin-6 bispecific antibodiesUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 1743US2017067116A1Biomarkers of Response to Cyclin D-CDK4/6 Targeted Therapies in CancerUNIV CALIFORNIA·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →